Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neutrolin vs Heparin for Hemodialysis Catheter Locking
NCT03425448Unknown
- Sponsor
- King Abdullah International Medical Research Center
- Start
- Apr 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of TauroLock-Hep500 in catheter-related bloodstream infection (CRBSI) and catheter-related thrombosis (CRT), sponsored by King Abdullah International Medical Research Center. Primary endpoint: Proportion of catheter related blood stream infections at 18 months. Status: unknown.
02
Drugs
TauroLock-Hep500
03
Conditions
catheter-related bloodstream infection (CRBSI)catheter-related thrombosis (CRT)
Beyond the preview
Go deeper on NCT03425448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03425448.